Genomic analysis of fibrolamellar hepatocellular carcinoma

Human Molecular Genetics

Volumn 24, Issue 1, 2015, Pages 50-63

  Xu, Lei ^a   Hazard, Florette K ^a,b   Zmoos, Anne Flore ^a   Jahchan, Nadine ^a   Chaib, Hassan ^a   Garfin, Phillip M ^a   Rangaswami, Arun ^a   Snyder, Michael P ^a   Sage, Julien ^a  

^a STANFORD UNIVERSITY   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE; HEAT SHOCK PROTEIN; HYBRID PROTEIN; PROTEIN VARIANT; TRANSCRIPTOME; CLPTM1L PROTEIN, HUMAN; DNAJB1 PROTEIN, HUMAN; GLIS3 PROTEIN, HUMAN; HEAT SHOCK PROTEIN 40; MEMBRANE PROTEIN; PRKCA PROTEIN, HUMAN; PROTEIN KINASE C ALPHA; TRANSCRIPTION FACTOR; TUMOR PROTEIN;

ADULT; ARTICLE; CONTROLLED STUDY; COPY NUMBER VARIATION; DNA SEQUENCE; ENZYME ACTIVE SITE; ENZYME ACTIVITY; FIBROLAMELLAR HEPATOCELLULAR CARCINOMA; FUSION GENE; GENE CLPTM 1 L; GENE DELETION; GENE DNAJB 1; GENE FUSION; GENE GLIS 3; GENE PRKCA; GENE TRANSLOCATION; GENETIC ASSOCIATION; GENOMICS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CANCER; LIVER CANCER CELL LINE; LIVER CARCINOGENESIS; MIDDLE AGED; ONCOGENE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RARE DISEASE; RNA SEQUENCE; SOMATIC MUTATION; ADOLESCENT; CHILD; GENETICS; GENOME-WIDE ASSOCIATION STUDY; HELA CELL LINE; HIGH THROUGHPUT SEQUENCING; INFANT; LIVER CELL CARCINOMA; LIVER TUMOR; METABOLISM; PRESCHOOL CHILD; SEQUENCE ANALYSIS; TUMOR CELL LINE;

ADOLESCENT; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CHILD; CHILD, PRESCHOOL; GENOME-WIDE ASSOCIATION STUDY; HELA CELLS; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HSP40 HEAT-SHOCK PROTEINS; HUMANS; INFANT; LIVER NEOPLASMS; MEMBRANE PROTEINS; NEOPLASM PROTEINS; PROTEIN KINASE C-ALPHA; RECOMBINANT FUSION PROTEINS; SEQUENCE ANALYSIS, DNA; SEQUENCE ANALYSIS, RNA; SEQUENCE DELETION; TRANSCRIPTION FACTORS; TRANSLOCATION, GENETIC;

EID: 84922279148     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddu418     Document Type: Article

References (69)

1. El-Serag, H.B. and Rudolph, K.L. (2007) Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology, 132, 2557-2576.
2. Arzumanyan, A., Reis, H.M. and Feitelson, M.A. (2013) Pathogenic mechanisms in HBV- and HCV-associated hepatocellular carcinoma. Nat. Rev. Cancer, 13, 123-135.
3. Klein, W.M., Molmenti, E.P., Colombani, P.M., Grover, D.S., Schwarz, K.B., Boitnott, J. and Torbenson, M.S. (2005) Primary liver carcinoma arising in people younger than 30 years. Am. J. Clin. Pathol., 124, 512-518.
4. Ward, S.C. and Waxman, S. (2011) Fibrolamellar carcinoma: a review with focus on genetics and comparison to other malignant primary liver tumors. Semin. Liver Dis., 31, 61-70.
5. El-Serag, H.B. and Davila, J.A. (2004) Is fibrolamellar carcinoma different from hepatocellular carcinoma? A US population-based study. Hepatology, 39, 798-803.
6. Kakar, S., Burgart, L.J., Batts, K.P., Garcia, J., Jain, D. and Ferrell, L.D. (2005) Clinicopathologic features and survival in fibrolamellar carcinoma: comparison with conventional hepatocellular carcinoma with and without cirrhosis. Mod. Pathol., 18, 1417-1423.
7. Craig, J.R., Peters, R.L., Edmondson, H.A. and Omata, M. (1980) Fibrolamellar carcinoma of the liver: a tumor of adolescents and young adults with distinctive clinico-pathologic features. Cancer, 46, 372-379.
8. Liu, S., Chan, K.W., Wang, B. and Qiao, L. (2009) Fibrolamellar hepatocellular carcinoma. Am. J. Gastroenterol., 104, 2617-2624. quiz 2625.
9. Yamashita, T., Forgues, M., Wang,W., Kim, J.W., Ye, Q., Jia, H., Budhu, A., Zanetti, K.A., Chen, Y., Qin, L.X. et al. (2008) EpCAM and alpha-fetoprotein expression defines novel prognostic subtypes of hepatocellular carcinoma. Cancer Res., 68, 1451-1461.
10. Ward, S.C., Huang, J., Tickoo, S.K., Thung, S.N., Ladanyi, M. and Klimstra, D.S. (2010) Fibrolamellar carcinoma of the liver exhibits immunohistochemical evidence of both hepatocyte and bile duct differentiation. Mod. Pathol., 23, 1180-1190.
11. Ross, H.M., Daniel, H.D., Vivekanandan, P., Kannangai, R., Yeh, M.M., Wu, T.T., Makhlouf, H.R. and Torbenson, M. (2011) Fibrolamellar carcinomas are positive for CD68. Mod. Pathol., 24, 390-395.
12. Oikawa, T., Kamiya, A., Zeniya, M., Chikada, H., Hyuck, A.D., Yamazaki, Y., Wauthier, E., Tajiri, H., Miller, L.D., Wang, X.W. et al. (2013) Sal-like protein 4 (SALL4), a stem cell biomarker in liver cancers. Hepatology, 57, 1469-1483.
13. Van Eyken, P., Sciot, R., Brock, P., Casteels-Van Daele, M., Ramaekers, F.C. and Desmet, V.J. (1990) Abundant expression of cytokeratin 7 in fibrolamellar carcinoma of the liver. Histopathology, 17, 101-107.
14. Kannangai, R., Vivekanandan, P., Martinez-Murillo, F., Choti, M. and Torbenson, M. (2007) Fibrolamellar carcinomas show overexpression of genes in the RAS, MAPK, PIK3, and xenobiotic degradation pathways. Hum. Pathol., 38, 639-644.
15. Buckley, A.F., Burgart, L.J. and Kakar, S. (2006) Epidermal growth factor receptor expression and gene copy number in fibrolamellar hepatocellular carcinoma. Hum. Pathol., 37, 410-414.
16. Cieply, B., Zeng, G., Proverbs-Singh, T., Geller, D.A. and Monga, S.P. (2009) Unique phenotype of hepatocellular cancers with exon-3 mutations in beta-catenin gene. Hepatology, 49, 821-831.
17. Orsatti, G., Hytiroglou, P., Thung, S.N., Ishak, K.G. and Paronetto, F. (1997) Lamellar fibrosis in the fibrolamellar variant of hepatocellular carcinoma: a role for transforming growth factor beta. Liver, 17, 152-156.
18. Li, W., Tan, D., Zenali, M.J. and Brown, R.E. (2010) Constitutive activation of nuclear factor-kappa B (NF-kB) signaling pathway in fibrolamellar hepatocellular carcinoma. Int. J. Clin. Exp. Pathol., 3, 238-243.
19. Wilczek, E., Szparecki, G., Lukasik, D., Koperski, L., Winiarska, M., Wilczynski, G.M., Wasiutynski, A. and Gornicka, B. (2012) Loss of the orphan nuclear receptor SHP is more pronounced in fibrolamellar carcinoma than in typical hepatocellular carcinoma. PLoS ONE, 7, e30944.
20. Njei, B., Konjeti, V.R. and Ditah, I. (2014) Prognosis of patients with fibrolamellar hepatocellular carcinoma versus conventional hepatocellular carcinoma: a systematic review and meta-analysis. Gastrointest. Cancer Res., 7, 49-54.
21. Stevens, W.R., Johnson, C.D., Stephens, D.H. and Nagorney, D.M. (1995) Fibrolamellar hepatocellular carcinoma: stage at presentation and results of aggressive surgical management. AJR Am. J. Roentgenol., 164, 1153-1158.
22. Katzenstein, H.M., Krailo, M.D., Malogolowkin, M.H., Ortega, J.A., Qu, W., Douglass, E.C., Feusner, J.H., Reynolds, M., Quinn, J.J., Newman, K. et al. (2003) Fibrolamellar hepatocellular carcinoma in children and adolescents. Cancer, 97, 2006-2012.
23. Ang, C.S., Kelley, R.K., Choti, M.A., Cosgrove, D.P., Chou, J.F., Klimstra, D., Torbenson, M.S., Ferrell, L., Pawlik, T.M., Fong, Y. et al. (2013) Clinicopathologic characteristics and survival outcomes of patients with fibrolamellar carcinoma: data from the fibrolamellar carcinoma consortium. Gastrointest. Cancer Res., 6, 3-9.
24. Chun, Y.S. and Zimmitti, G. (2013) Fibrolamellar variant of hepatocellular carcinoma. Recent Results Cancer Res., 190, 101-110.
25. Honeyman, J.N., Simon, E.P., Robine, N., Chiaroni-Clarke, R., Darcy, D.G., Lim, I.I., Gleason, C.E., Murphy, J.M., Rosenberg, B.R., Teegan, L. et al. (2014) Detection of a recurrent DNAJB1-PRKACA chimeric transcript in fibrolamellar hepatocellular carcinoma. Science, 343, 1010-1014.
26. Vivekanandan, P., Micchelli, S.T. and Torbenson, M. (2009) Anterior gradient-2 is overexpressed by fibrolamellar carcinomas. Hum. Pathol., 40, 293-299.
27. Collier, N.A., Weinbren, K., Bloom, S.R., Lee, Y.C., Hodgson, H.J. and Blumgart, L.H. (1984) Neurotensin secretion by fibrolamellar carcinoma of the liver. Lancet, 1, 538-540.
28. Wang, J.H., Dhillon, A.P., Sankey, E.A., Wightman, A.K., Lewin, J.F. and Scheuer, P.J. (1991) 'Neuroendocrine' differentiation in primary neoplasms of the liver. J. Pathol., 163, 61-67.
29. Malouf, G.G., Job, S., Paradis, V., Fabre, M., Brugieres, L., Saintigny, P., Vescovo, L., Belghiti, J., Branchereau, S., Faivre, S. et al. (2014) Transcriptional profiling of pure fibrolamellar hepatocellular carcinoma reveals an endocrine signature. Hepatology, 59, 2228-2237.
30. Ding, S.F., Delhanty, J.D., Bowles, L., Dooley, J.S., Wood, C.B. and Habib, N.A. (1993) Infrequent chromosome allele loss in fibrolamellar carcinoma. Br. J. Cancer, 67, 244-246.
31. Guichard, C., Amaddeo, G., Imbeaud, S., Ladeiro, Y., Pelletier, L., Maad, I.B., Calderaro, J., Bioulac-Sage, P., Letexier, M., Degos, F. et al. (2012) Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma. Nat. Genet., 44, 694-698.
32. Fujimoto, A., Totoki, Y., Abe, T., Boroevich, K.A., Hosoda, F., Nguyen, H.H., Aoki, M., Hosono, N., Kubo, M., Miya, F. et al. (2012) Whole-genome sequencing of liver cancers identifies etiological influences on mutation patterns and recurrent mutations in chromatin regulators. Nat. Genet., 44, 760-764.
33. Huang, J., Deng, Q., Wang, Q., Li, K.Y., Dai, J.H., Li, N., Zhu, Z.D., Zhou, B., Liu, X.Y., Liu, R.F. et al. (2012) Exome sequencing of hepatitis B virus-associated hepatocellular carcinoma. Nat. Genet., 44, 1117-1121.
34. Vogelstein, B., Papadopoulos, N., Velculescu, V.E., Zhou, S., Diaz, L.A. Jr. and Kinzler, K.W. (2013) Cancer genome landscapes. Science, 339, 1546-1558.
35. Marchio, A., Pineau, P., Meddeb, M., Terris, B., Tiollais, P., Bernheim, A. and Dejean, A. (2000) Distinct chromosomal abnormality pattern in primary liver cancer of non-B, non-C patients. Oncogene, 19, 3733-3738.
36. Wilkens, L., Bredt, M., Flemming, P., Kubicka, S., Klempnauer, J. and Kreipe, H. (2000) Cytogenetic aberrations in primary and recurrent fibrolamellar hepatocellular carcinoma detected by comparative genomic hybridization. Am. J. Clin. Pathol., 114, 867-874.
37. Hattori, H., Liu, Y.C., Tohnai, I., Ueda, M., Kaneda, T., Kobayashi, T., Tanabe, K. and Ohtsuka, K. (1992) Intracellular localization and partial amino acid sequence of a stress-inducible 40-kDa protein in HeLa cells. Cell Struct. Funct., 17, 77-86.
38. Dyachok, O., Isakov, Y., Sagetorp, J. and Tengholm, A. (2006) Oscillations of cyclic AMP in hormone-stimulated insulin-secreting beta-cells. Nature, 439, 349-352.
39. Rafnar, T., Sulem, P., Stacey, S.N., Geller, F., Gudmundsson, J., Sigurdsson, A., Jakobsdottir, M., Helgadottir, H., Thorlacius, S., Aben, K.K. et al. (2009) Sequence variants at theTERT-CLPTM1Llocus associate withmanycancer types. Nat. Genet., 41, 221-227.
40. Senee, V., Chelala, C., Duchatelet, S., Feng, D., Blanc, H., Cossec, J.C., Charon, C., Nicolino, M., Boileau, P., Cavener, D.R. et al. (2006) Mutations in GLIS3 are responsible for a rare syndrome with neonatal diabetes mellitus and congenital hypothyroidism. Nat. Genet., 38, 682-687.
41. Stratton, M.R., Campbell, P.J. and Futreal, P.A. (2009) The cancer genome. Nature, 458, 719-724.
42. Mitelman, F., Johansson, B. and Mertens, F. (2007) The impact of translocations and gene fusions on cancer causation. Nat. Rev. Cancer, 7, 233-245.
43. Marshall, G.M., Carter, D.R., Cheung, B.B., Liu, T., Mateos, M.K., Meyerowitz, J.G. and Weiss, W.A. (2014) The prenatal origins of cancer. Nat. Rev. Cancer, 14, 277-289.
44. Zhang, J., Benavente, C.A., McEvoy, J., Flores-Otero, J., Ding, L., Chen, X., Ulyanov, A., Wu, G., Wilson, M., Wang, J. et al. (2012) A novel retinoblastoma therapy from genomic and epigenetic analyses. Nature, 481, 329-334.
45. Westbrook, C.A., Hooberman, A.L., Spino, C., Dodge, R.K., Larson, R.A., Davey, F., Wurster-Hill, D.H., Sobol, R.E., Schiffer, C. and Bloomfield, C.D. (1992) Clinical significance of the BCR-ABL fusion gene in adult acute lymphoblastic leukemia: a Cancer and Leukemia Group B Study (8762). Blood, 80, 2983-2990.
46. Thirman, M.J., Gill, H.J., Burnett, R.C., Mbangkollo, D., McCabe, N.R., Kobayashi, H., Ziemin-van der Poel, S., Kaneko, Y., Morgan, R., Sandberg, A.A. et al. (1993) Rearrangement of the MLL gene in acute lymphoblastic and acute myeloid leukemias with 11q23 chromosomal translocations. N. Engl. J. Med., 329, 909-914.
47. Davis, R.J., D'Cruz, C.M., Lovell, M.A., Biegel, J.A. and Barr, F.G. (1994) Fusion of PAX7 to FKHR by the variant t(1;13)(p36;q14) translocation in alveolar rhabdomyosarcoma. Cancer Res., 54, 2869-2872.
48. Sorensen, P.H., Lessnick, S.L., Lopez-Terrada, D., Liu, X.F., Triche, T.J. and Denny, C.T. (1994) A second Ewing's sarcoma translocation, t(21;22), fuses the EWS gene to another ETS-family transcription factor, ERG. Nat. Genet., 6, 146-151.
49. Golub, T.R., Barker, G.F., Bohlander, S.K., Hiebert, S.W., Ward, D.C., Bray-Ward, P., Morgan, E., Raimondi, S.C., Rowley, J.D. and Gilliland, D.G. (1995) Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemia. Proc. Natl. Acad. Sci. USA, 92, 4917-4921.
50. Barr, F.G., Nauta, L.E., Davis, R.J., Schafer, B.W., Nycum, L.M. and Biegel, J.A. (1996) In vivo amplification of the PAX3-FKHR and PAX7-FKHR fusion genes in alveolar rhabdomyosarcoma. Hum. Mol. Genet., 5, 15-21.
51. Knezevich, S.R., Garnett, M.J., Pysher, T.J., Beckwith, J.B., Grundy, P.E. and Sorensen, P.H. (1998) ETV6-NTRK3 gene fusions and trisomy 11 establish a histogenetic link between mesoblastic nephroma and congenital fibrosarcoma. Cancer Res., 58, 5046-5048.
52. Raza-Egilmez, S.Z., Jani-Sait, S.N., Grossi, M., Higgins, M.J., Shows, T.B. and Aplan, P.D. (1998) NUP98-HOXD13 gene fusion in therapy-related acute myelogenous leukemia. Cancer Res., 58, 4269-4273.
53. Rubnitz, J.E., Pui, C.H. and Downing, J.R. (1999) The role of TEL fusion genes in pediatric leukemias. Leukemia, 13, 6-13.
54. Argani, P., Lui, M.Y., Couturier, J., Bouvier, R., Fournet, J.C. and Ladanyi, M. (2003) A novel CLTC-TFE3 gene fusion in pediatric renal adenocarcinoma with t(X;17)(p11.2;q23). Oncogene, 22, 5374-5378.
55. Kleinman, C.L., Gerges, N., Papillon-Cavanagh, S., Sin-Chan, P., Pramatarova, A., Quang, D.A., Adoue, V., Busche, S., Caron, M., Djambazian, H. et al. (2014) Fusion of TTYH1 with the C19MC microRNA cluster drives expression of a brain-specific DNMT3B isoform in the embryonal brain tumor ETMR. Nat. Genet., 46, 39-44.
56. Nowell, P.C., Emanuel, B.S., Finan, J.B., Erikson, J. and Croce, C.M. (1984) Chromosome rearrangements in oncogenesis. Microbiol. Sci., 1, 223-228.
57. Bonaglia, M.C., Marelli, S., Novara, F., Commodaro, S., Borgatti, R., Minardo, G., Memo, L., Mangold, E., Beri, S., Zucca, C. et al. (2010) Genotype-phenotype relationship in three cases with overlapping 19p13.12 microdeletions. Eur. J. Hum. Genet., 18, 1302-1309.
58. Jahchan, N.S., Dudley, J.T., Mazur, P.K., Flores, N., Yang, D., Palmerton, A., Zmoos, A.F., Vaka, D., Tran, K.Q., Zhou, M. et al. (2013) A drug repositioning approach identifies tricyclic antidepressants as inhibitors of small cell lung cancer and other neuroendocrine tumors. Cancer Discov., 3, 1364-1377.
59. Deeble, P.D., Cox, M.E., Frierson, H.F. Jr., Sikes, R.A., Palmer, J.B., Davidson, R.J., Casarez, E.V., Amorino, G.P. and Parsons, S.J. (2007) Androgen-independent growth and tumorigenesis of prostate cancer cells are enhanced by the presence of PKA-differentiated neuroendocrine cells. Cancer Res., 67, 3663-3672.
60. Park, M.H., Lee, H.S., Lee, C.S., You, S.T., Kim, D.J., Park, B.H., Kang, M.J., Heo, W.D., Shin, E.Y., Schwartz, M.A. et al. (2013) p21-Activated kinase 4 promotes prostate cancer progression through CREB. Oncogene, 32, 2475-2482.
61. Goh, G., Scholl, U.I., Healy, J.M., Choi, M., Prasad, M.L., Nelson-Williams, C., Kuntsman, J.W., Korah, R., Suttorp, A.C., Dietrich, D. et al. (2014) Recurrent activating mutation in PRKACA in cortisol-producing adrenal tumors. Nat. Genet., 46, 613-617.
62. Cao, Y., He, M., Gao, Z., Peng, Y., Li, Y., Li, L., Zhou, W., Li, X., Zhong, X., Lei, Y. et al. (2014) Activating hotspot L205R mutation in PRKACA and adrenal Cushing's syndrome. Science, 344, 913-917.
63. Sato, Y., Maekawa, S., Ishii, R., Sanada, M., Morikawa, T., Shiraishi, Y., Yoshida, K., Nagata, Y., Sato-Otsubo, A., Yoshizato, T. et al. (2014) Recurrent somatic mutations underlie corticotropin-independent Cushing's syndrome. Science, 344, 917-920.
64. Kakar, S., Chen, X., Ho, C., Burgart, L.J., Sahai, V., Dachrut, S., Yabes, A., Jain, D. and Ferrell, L.D. (2009) Chromosomal changes in fibrolamellar hepatocellular carcinoma detected by array comparative genomic hybridization. Mod. Pathol., 22, 134-141.
65. Trankenschuh, W., Puls, F., Christgen, M., Albat, C., Heim, A., Poczkaj, J., Fleming, P., Kreipe, H. and Lehmann, U. (2010) Frequent and distinct aberrations of DNA methylation patterns in fibrolamellar carcinoma of the liver. PLoS ONE, 5, e13688.
66. Vivekanandan, P., Daniel, H., Yeh, M.M. and Torbenson, M. (2010) Mitochondrial mutations in hepatocellular carcinomas and fibrolamellar carcinomas. Mod. Pathol., 23, 790-798.
67. Haiman, C.A., Chen, G.K., Vachon, C.M., Canzian, F., Dunning, A., Millikan, R.C., Wang, X., Ademuyiwa, F., Ahmed, S., Ambrosone, C.B. et al. (2011) A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor-negative breast cancer. Nat. Genet., 43, 1210-1214.
68. Drmanac, R., Sparks, A.B., Callow, M.J., Halpern, A.L., Burns, N.L., Kermani, B.G., Carnevali, P., Nazarenko, I., Nilsen, G.B., Yeung, G. et al. (2010) Human genome sequencing using unchained base reads on self-assembling DNA nanoarrays. Science, 327, 78-81.
69. Viatour, P., Somervaille, T.C., Venkatasubrahmanyam, S., Kogan, S., McLaughlin, M.E., Weissman, I.L., Butte, A.J., Passegue, E. and Sage, J. (2008) Hematopoietic stem cell quiescence is maintained by compound contributions of the retinoblastoma gene family. Cell Stem Cell, 3, 416-428.